Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an average of 50 pounds (22.8 kilograms) ...

It comes days after CVS Health's decision to drop Zepbound from some lists of medicines it covers for reimbursement, instead favoring Wegovy. Zepbound helped nearly 25% more participants lose more ...

Allison Stange lost 40 pounds since starting Zepbound in April 2024, improving both her blood pressure and sleep apnea. Now ...

Eli Lilly rose Friday after topping Wall Street's first-quarter expectations. Eli Lilly stock bounced back after tumbling Thursday after CVS' Caremark selected Novo Nordisk's Wegovy as its preferred ...

Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound.

Lilly is already stocking $550 million in pre-launch inventory to prevent the sort of shortages that plagued its rollout of Mounjaro and Zepbound, Orforglipron complements Mounjaro ...

and Zepbound, which treats obesity. Compound medicine providers were allowed to make and distribute copycat versions of tirzepatide injection products until December 2024, when the FDA issued a ...

Pharmaceutical companies like Novo Nordisk and Eli Lilly took the world by storm last year with a new generation of so-called GLP-1 diet products - Ozempic, Wegovy and Zepbound. The drugs were ...

Zepbound (tirzepatide) is a once-a-week injectable weight-loss medication. It helps reduce your appetite by influencing two hormones: glucagon-like peptide-1 (GLP-1) and glucose-dependent ...

CVS Group has agreed to sell its crematorium business with plans to reinvest some of the cash in Australia after an extended period of regulatory pressure in the UK. Britain's veterinary sector ...

In its first-quarter 2025 investor letter, Patient Capital Opportunity Equity Strategy highlighted stocks such as CVS Health Corporation (NYSE:CVS). CVS Health Corporation (NYSE:CVS) is a US-based ...

(ABC News) Eli Lilly is suing compounding pharmacies still selling their versions of tirzepatide (Zepbound) after the shortage has been declared over. (NPR) Layoffs and budget cuts at HHS have ...